| Targeting cancer associated fibroblasts in liver fibrosis and liver cancer using nanocarriers L Kaps, D Schuppan Cells 9 (9), 2027, 2020 | 124 | 2020 |
| Gold (I)–NHC complexes of antitumoral diarylimidazoles: Structures, cellular uptake routes and anticancer activities L Kaps, B Biersack, H Müller-Bunz, K Mahal, J Münzner, M Tacke, ... Journal of Inorganic Biochemistry 106 (1), 52-58, 2012 | 110 | 2012 |
| Cylindrical brush polymers with polysarcosine side chains: a novel biocompatible carrier for biomedical applications C Hörtz, A Birke, L Kaps, S Decker, E Wächtersbach, K Fischer, ... Macromolecules 48 (7), 2074-2086, 2015 | 106 | 2015 |
| The role of p53 dysfunction in colorectal cancer and its implication for therapy M Michel, L Kaps, A Maderer, PR Galle, M Moehler Cancers 13 (10), 2296, 2021 | 88 | 2021 |
| Ferrocenyl‐coupled N‐heterocyclic carbene complexes of gold (I): a successful approach to multinuclear anticancer drugs JK Muenzner, B Biersack, A Albrecht, T Rehm, U Lacher, W Milius, ... Chemistry–A European Journal 22 (52), 18953-18962, 2016 | 76 | 2016 |
| SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles N Leber, L Kaps, M Aslam, J Schupp, A Brose, D Schäffel, K Fischer, ... Journal of Controlled Release 248, 10-23, 2017 | 70 | 2017 |
| Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease L Kaps, C Labenz, PR Galle, J Weinmann-Menke, K Kostev, ... United European Gastroenterology Journal 8 (8), 942-948, 2020 | 65 | 2020 |
| Gold (I) Biscarbene Complexes Derived from Vascular‐Disrupting Combretastatin A‐4 Address Different Targets and Show Antimetastatic Potential JK Muenzner, B Biersack, H Kalie, IC Andronache, L Kaps, D Schuppan, ... ChemMedChem 9 (6), 1195-1204, 2014 | 60 | 2014 |
| Novel benzyl‐or 4‐cyanobenzyl‐substituted N‐heterocyclic (Bromo)(carbene) silver (I) and (Carbene)(chloro) gold (I) complexes: synthesis and preliminary cytotoxicity studies S Patil, A Deally, F Hackenberg, L Kaps, H Müller‐Bunz, R Schobert, ... Helvetica Chimica Acta 94 (9), 1551-1562, 2011 | 56 | 2011 |
| In vivo gene‐silencing in fibrotic liver by siRNA‐loaded cationic nanohydrogel particles L Kaps, L Nuhn, M Aslam, A Brose, F Foerster, S Rosigkeit, P Renz, ... Advanced healthcare materials 4 (18), 2809-2815, 2015 | 54 | 2015 |
| Squaric ester-based, pH-degradable nanogels: modular nanocarriers for safe, systemic administration of toll-like receptor 7/8 agonistic immune modulators A Huppertsberg, L Kaps, Z Zhong, S Schmitt, J Stickdorn, K Deswarte, ... Journal of the American Chemical Society 143 (26), 9872-9883, 2021 | 53 | 2021 |
| Reductive Decationizable block copolymers for stimuli‐responsive mRNA delivery L Nuhn, L Kaps, M Diken, D Schuppan, R Zentel Macromolecular rapid communications 37 (11), 924-933, 2016 | 52 | 2016 |
| In vivo siRNA delivery to immunosuppressive liver macrophages by α-mannosyl-functionalized cationic nanohydrogel particles L Kaps, N Leber, A Klefenz, N Choteschovsky, R Zentel, L Nuhn, ... Cells 9 (8), 1905, 2020 | 48 | 2020 |
| Dextran-based therapeutic nanoparticles for hepatic drug delivery F Foerster, D Bamberger, J Schupp, M Weilbächer, L Kaps, S Strobl, ... Nanomedicine 11 (20), 2663-2677, 2016 | 48 | 2016 |
| Incident dementia in elderly patients with nonalcoholic fatty liver disease in Germany C Labenz, K Kostev, L Kaps, PR Galle, JM Schattenberg Digestive diseases and sciences 66 (9), 3179-3185, 2021 | 46 | 2021 |
| Monitoring translation activity of mRNA-loaded nanoparticles in mice S Rosigkeit, M Meng, C Grunwitz, P Gomes, A Kreft, N Hayduk, R Heck, ... Molecular pharmaceutics 15 (9), 3909-3919, 2018 | 45 | 2018 |
| Validation of the clinical frailty scale for the prediction of mortality in patients with liver cirrhosis WM Kremer, M Nagel, M Reuter, M Hilscher, M Michel, L Kaps, J Labenz, ... Clinical and translational gastroenterology 11 (7), e00211, 2020 | 34 | 2020 |
| Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cells F Foerster, S Boegel, R Heck, G Pickert, N Rüssel, S Rosigkeit, M Bros, ... Oncoimmunology 7 (4), e1409929, 2018 | 31 | 2018 |
| Symptom burden and treatment response in patients with primary biliary cholangitis (PBC) L Kaps, A Grambihler, B Yemane, M Nagel, C Labenz, P Ploch, M Michel, ... Digestive Diseases and Sciences 65, 3006-3013, 2020 | 30 | 2020 |
| α‐Mannosyl‐Functionalized Cationic Nanohydrogel Particles for Targeted Gene Knockdown in Immunosuppressive Macrophages N Leber, L Kaps, A Yang, M Aslam, M Giardino, A Klefenz, ... Macromolecular bioscience 19 (7), 1900162, 2019 | 29 | 2019 |